Publications

Journal of the National Cancer Institute. 2002-04-03; 94.7: 513-21.

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ

PMID: 11929952

Abstract

New tumor markers and markers of tumor progression are needed for improved staging and for better assessment of treatment of many cancers. Gene expression profiling techniques offer the opportunity to discover such markers. We investigated the feasibility of sample pooling strategy in combination with a novel analysis algorithm to identify markers.

Metrics